Baron Opportunity Fund

3 / 5 Stars
2 1 2 2 4
Zacks Investment Research
1 (Strong Buy)
Standard & Poor's
1 / 5 Stars
E+ (Sell)

#98 in Mid-Cap Growth

U.S. News evaluated 221 Mid-Cap Growth Funds. Our list highlights the top-rated funds for long-term investors based on the ratings of leading fund industry researchers.

See all Baron Capital Group funds

See full Mid-Cap Growth rankings

See more fund rankings


The fund has returned 20.31 percent over the past year, 10.42 percent over the past three years, 18.53 percent over the past five years, and 10.12 percent over the past decade.

Trailing Returns Updated 06.30.2014
Year to date -0.7%
1 Year 20.3%
3 Years (Annualized) 10.4%
5 Years (Annualized) 18.5%
10 Years (Annualized) 10.1%

See more BIOPX performance


The investment seeks capital appreciation through investments primarily in growth companies that benefit from technology advances. The fund invests primarily in equity securities in the form of common stock of high growth businesses selected for their capital appreciation potential. It will invest at least 65% of its assets in equity securities of companies with market capitalizations between $1 billion and $15 billion at the time of purchase. The Adviser may invest in companies in any sector or industry that it believes will benefit from innovations and advances in technology.


Fees are Low compared to funds in the same category.
Baron Opportunity Fund has an expense ratio of 1.37 percent.

See more BIOPX fees


Risk is Above Average compared to funds in the same category according to Morningstar.

See more BIOPX risk

See Also:

Top Baron Capital Group Funds

Mid-Cap Growth Funds

Highest Returns (10-year)

See More Funds

Quotes delayed at least 15 minutes. Market data provided by Interactive Data and powered by Interactive Data Managed Solutions. Fund data provided by Interactive Data and Morningstar. Contact U.S. News Best Funds. Use of this website constitutes acceptance of the Best Funds Terms and Conditions of Use.